Business
A U.S. appeals court Friday limited the ability of generic-drug companies to challenge patents in a ruling affecting Pfizer Inc.’
Jan. 22, 2005
Science & Medicine
The Food and Drug Administration approved the first generic version of EpiPen on Thursday, a move that will bring new competition for the lifesaving allergy injection that helped spark public furor over high drug prices.
Aug. 16, 2018
Teva Pharmaceutical said Friday that it would buy rival generic drug maker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva’s dominance as the world’s biggest generic drug maker.
July 19, 2008
Federal regulators announced Thursday that Teva Pharmaceuticals Industries will pay $1.2 billion to settle charges that one of its subsidiaries illegally blocked the launch of low-cost generic versions of the blockbuster sleeping pill Provigil.
May 28, 2015
The ruling stems from a Teva Pharmaceutical lawsuit which sought to stop Pfizer from selling its epilepsy prescription.
June 7, 2005
Pharmaceutical company Allergan has agreed to sell its generic drug unit to Teva Pharmaceutical Industries of Israel for $40.5 billion, a move that will enable Allergan to focus on branded drugs, including blockbuster wrinkle treatment Botox.
July 27, 2015
Teva Pharmaceutical offers $6.8 billion for Cephalon
May 3, 2011
Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.
March 30, 2015
The $7.4-billion deal would create the world’s largest generic drug company and could spur consolidation.
July 26, 2005
World & Nation
As the United States struggles amid an Adderall shortage, pharmacies in Mexico sell fake ADHD meds by the bottle
Dec. 21, 2023